Zhipu AI Emerges in Hong Kong After Raising $558M in IPO, Marking China’s First Large-Scale Generative AI Public Offering January 8, 2026 — 09:50
Insilico Medicine Leads Hong Kong Biotech IPO with AI Drug Discovery Prowess December 30, 2025 — 19:00
China’s New Guidelines on Overseas Fund Repatriation to Tighten Cross-Border Financing Oversight December 28, 2025 — 02:40
Chinese Insurance Companies Poised to Embrace Cryptocurrency Following Hong Kong Regulation Review December 22, 2025 — 21:10